Work

MA 15.08 Safety and Efficacy of Osimertinib in Treating an EGFR-Mutant Lung Cancer Patient with a Germline EGFR T790M Mutation

Year: 2017

Type: article

Study design: Case Report

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.09.590

Authors: W. Ma, J. Gong, J. Shan, D. Lewis, W. Xiao, J. Hung, E.H. Moore, Y. Zhang, N.Z. Mans, J. Welborn, K.S. Lam, T. Li

Institutions: University of California Davis Medical Center, UC Davis Comprehensive Cancer Center, Albert Einstein College of Medicine, University of California, Davis

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2767594233

FWCI:

Cites:

Cited by:

Related to: 10